[1]
M. U. Şener, T. Çiçek, and A. Öztürk, “Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational study”, Sao Paulo Med J, vol. 140, no. 5, pp. 627–635, Sep. 2022.